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Summary 
Recent  studies have revealed  that  10-20%  of CD4+8 -  or CD4-8-  thymocyte populations 
contain NKI.1 + T  cell receptor (TCR)-cff~ + cells. This subpopulation shows characteristics 
that are different from NKI.1-  CD4 § or NKI.1-  CD8 + T calls and seems to have developed 
in a manner different from NKI.1-  T  cells. Although extensive studies have been performed 
on the NKI.1 + TCR-od~8 + thymocytes, the physiological role of the NKI.1 + TCR-c~/~/+ 
thymocytes has been totally unclear. In the present study, we found that fleshly isolated NKI.1 + 
TCR-odB + thymocytes, but neither whole thymocytes nor lymph node T cells, directly killed 
CD4 +8 § thymocytes from normal syngeneic or allogeneic mice by using a long-term cytotoxic 
assay in which flow cytometry was used to detect the cytotoxidty. However, only weak cytotoxicity 
was detected against thymocytes from lpr mice on which the Fas antigen that transduces signals 
for apoptosis into the cells is not expressed. Furthermore, the NKI.1 + TCR-ot/B + thymocytes 
exhibited high cytotoxicity against T lymphoma targets transfected withj~s genes as compared 
with the parental T lymphoma targets or target cells transfected with mutatedJas genes, which 
lack the function of transducing signals.  On the other hand, NKI.1 § effector thymocytes from 
gld mice that carry a point mutation in Fas ligand did not kill thymocyte targets from normal 
mice. The present findings, thus, consistently suggest that the NKI.1 + TCR-ot/~8 + thymocytes 
kill  a  subpopulation  among CD4+8 +  thymocytes via  Fas  antigen  and  in  this way regulate 
generation of T  lineage cells in the thymus. 
T 
hymocytes consist of four major CD4-8-,  CD4+8 +, 
CD4+8-,  and CD4-8 + populations. CD4-8-  thymo- 
cytes are thought to be potent progenitors that develop into 
mature CD4 +  8 -  or CD4- 8 + thymocytes through CD4 +  8 + 
thymocytes.  However,  in  adult  mice  of  most  strains, 
~10-20%  of the CD4-8-  thymocytes expresses low levels 
of TCR-c~/~/  (TCR-od~  low) (1,  2).  The CD4-8-  TCR- 
a/fl l~  population  has  a  phenotype  similar  to  that  of 
memory T  cells (i.e.,  CD44 +, intercellular adhesion mole- 
cule 1+, MEL-14-  Thy-l+, CD5 + and heat-stable antigen 
[HSA]-I) (3, 4).  Interestingly, '~40-50%  of the CD4-8- 
TCR-cr/B  l~  thymocytes expresses VB8.2 TCR (1, 2, 4, 5), 
whereas only ~10--20%  of cells in ordinary CD4+8 -  or 
CD4-8 §  population  bearing  high  levels  of  TCR-od~ 
1 Abbreviations  used in this paper'. HSA, heat-stable antigen; LN T, lymph 
node T cells. 
(TCR-~/~ high) express  the  V~8.2  TCR.  The  CD4-8- 
TCR-oL/~  l~  thymocyte population can proliferate and se- 
crete several kinds of lymphokines upon stimulation via the 
TCR  (6-8).  Furthermore,  it  has  been  reported  that  the 
CD4-8-  TCR-od~  l~  thymocytes express NKI.1 antigens 
in mice of NKI.1 type (4, 9). The NKI.1 § antigens are not 
expressed on major classical T  cells and have been thought 
to be a specific marker for NK cells (10,  11). The number 
of CD4-8-  NKI.1 +  TCR-c~//5  l~  thymocytes increases 
with age and they become a substantial population at rela- 
tively late stages in life (1, 5). On the other hand, we have 
recently found a NKI.1 + TCR-od/~/l~  subpopulation in a 
CD4+8 -  thymocyte population  (12,  13). The  NKI.1 § 
CD4+8-  thymocytes show characteristics similar to those 
of NKI.1 + CD4-8-  TCR<x/B l~  thymocytes in their sur- 
face phenotype,  TCR  V~  usage,  lymphokine production 
profile, and ontogeny, although lineage correlation between 
these two subpopulations has remained unclear. 
In  our  subsequent  study  (3),  we  demonstrated  that 
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chain and proliferate upon stimulation with recombinant IL-2. 
Furthermore, after stimulation with recombinant IL-2 the 
NKI.1 + TCR-ot/3 l~  thymocytes acquired cytotoxic activity 
against both normal thymocytes and several kinds of tumor 
cells.  Therefore,  the  NKI.1 +  TCR-ot/3  l~  thymocytes 
seemed  to be of functional T  cell lineage.  However, when 
freshly  isolated  NKI.1 +  TCR-a/3 l~  thymocytes  were 
evaluated  in  a  4-h  cytotoxic assay, we  could  not  detect 
significant cytotoxicity. Thus, physiological function of the 
NKI.1 + TCR-ot/3  l~  thymocytes was not uncovered. 
On the other hand, it has been demonstrated that most 
of the thymocytes  express considerable Fas antigens that trans- 
duce signals for apoptosis into cells (14, 15). The Fas antigen 
is  encoded by the  gene  at  the locus of the mouse lym- 
phoproliferation mutation tpr (16). Since mice carrying mu- 
tations homozygous at the lpr locus and actually lacking the 
Fas expression  have lymphadenopathy and autoimmune dis- 
eases, it seems that the expression  of the intact Fas antigen 
is related to the physiological development of T cells in normal 
mice.  However, the mechanism how the Fas antigen is in- 
volved in the normal T  cell development has been unclear. 
Identification of cells expressing Fas ligand, if present, in the 
thymus seems important to clarify the direct function of the 
Fas antigen in physiological conditions. 
In the present study, to elucidate the function of NKI.1 + 
TCR-ot/31~  thymocytes, we analyzed the cytotoxicity of 
freshly isolated NKI.1 +  TCR-cr/3  l~  thymocytes against 
thymocyte targets by using a long-term cytotoxic assay. We 
found that the freshly isolated NKI.1 § TCR-c~/3  l~  thymo- 
cytes exhibited considerable  cytotoxicity against CD4+8 + 
thymocytes. Furthermore the cytotoxicity was directly cor- 
related with the intact Fas expression  and Fas ligand expres- 
sion on the targets and effector cells, respectively. Thus, the 
NKI.1 + TCR-a/3 l~  thymocyte population seems to rep- 
resent a population that regulates thymocyte development 
via Fas antigen and Fas ligand interaction. 
Materials  and  Methods 
Mice.  C57BL/10 (B10), B10.BR/SgSnSIc  (B10.BR) mice were 
obtained  from the Shizuoka  Laboratory  Animal Cooperation  (Hama- 
matsu, Shizuoka Prefecture, Japan). C57BL/6J Jcl were obtained 
from the Japan Clea Animal Cooperation (Tokyo,  Japan). B6 Ipr/Ipr 
and B6 gld/gld were obtained from stock maintained in our animal 
facility at Hokkaido University. 
Antibodies andRea,gents.  Primary  n'tAbs used for immunofluores- 
cence staining and flow cytometry in the present experiments were 
2Cll (anti-CD3-e, a kind gift from Dr. J. A. Bluestone, Univer- 
sity of  Chicago, Chicago, IL) (17), H57.597 (anti-TCR-ct/3, a kind 
gift from Dr. R. T. Kubo, National  Jewish Center for Immunology, 
Denver, CO) (18), MEL-14 (anti-gp90  ~t-14) (19), J11d (anti-HSA) 
(20), PK-136 (anti-NKl.1) (purchased from American Type Cul- 
ture Collection, R.ockville, MD) (21), and 020-400 (anti-Lyt2.2) 
(Meiji Institute of Health, Kanagawa, Japan). PE anti-CD4 and 
FITC anti-CD8 mAbs were purchased from Becton Dickinson & 
Co. (Mountain View, CA). Fluorescence-labeled  secondary anti- 
bodies and avidin used herein were FITC anti-mouse IgG, FITC 
anti-rat IgG, FITC anti-hamster  IgG, biotin anti-hamster  IgG 
(Cappel Organon Teknika  Co., West Chester, PA), PE anti-mouse 
IgG, PE anti-rat IgG (Southern Biotechnology Associates, Bir- 
mingham,  AL),  PE-streptavidin,  and  TANDEM-streptavidin 
(Southern Biotechnology  Associates). Calcium ionophor (A23187) 
was purchased from Calbiochem-Novabiochem  Corp. (San  Diego, 
CA). 
Surface Marker Analysis.  Thymocytes were treated with anti- 
HSA mAb or mixture of anti-HSA and anti-CD8 mAbs followed 
by C treatment. The resultant cells were treated with Dynabeads 
coupled with anti-mouse or anti-rat IgG (Dynal, Oslo, Norway) 
to  completely remove CD8 +  or  HSA + cells. Thereafter,  the 
purified  HSA-  cells were stained with  anti-NKl.1  mAb  or 
medium  followed by biotin  anti-mouse  IgG  and  TANDEM- 
streptavidin.  After  blocking  the  nonspecific binding  site of 
anti-mouse IgG by purified mouse Ig, the cells were stained with 
PE anti-CD4 and FITC anti-CD8 mAbs (Fig. 1). On the other 
hand,  the  purified HSA-  CDS-  cells were mixed with anti- 
NKI.1, MEL-14, anti-CD4 mAb, or medium (control) followed 
by PE anti-mouse  IgG or PE anti-rat IgG. After blocking the 
nonspecific binding  site of anti-mouse  IgG or anti-rat IgG by 
purified mouse or rat Ig, the cells were mixed with anti-CD3 mAb 
or anti-TCR-c~/3 mAb followed by FITC anti-hamster IgG that 
had been preabsorbed with mouse and rat Ig (Fig. 2). The stained 
cells were analyzed by FACScan  |  (Becton Dickinson & Co.). 
Cell  Sorting.  To  prepare effector  cells, HSA-  MEL-14- 
CD4-8-,  HSA-  MEL-14- CD4+8 -,  HSA-  MEL-14- NKI.1 ~ 
CD8-,  HSA-  NKI.1 § CD8-,  HSA-  NKI.1-  CD8-,  HSA- 
TCR-~/3  high CD4+8 -,  and HSA-  TCR-ot/B t~  CD4+8 -  cells 
were purified by sorting. After purification of CDS- HSA- MEL- 
14- or CDS- HSA- cells from thymocytes of 6-10-wk-old mice, 
cells were stained with FITC anti-rat IgG/PE anti-CD4,  FITC 
anti-rat  IgG/anti-NKl.1/PE anti-mouse  IgG or FITC anti-rat 
IgG/anfi-TCR-cd~/biofin anti-hamster IgG/PE-streptavidin.  There- 
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Figure  1.  FACS  |  analysis  of 
HSA- thymocytes  from B10 mice. 
HSA-  thymocytes were stained 
with anti-CD4, CDS, and NKI.1 
mAbs. (A) NKI.1 expression of 
HSA-  thymocytes (hatched histo- 
gram,  control; open histogram, 
NKI.1). (B) CD4 and CD8 expres- 
sion on HSA- NKI.1-  or HSA- 
NKI.1 +  thymocytes from B10 
mice. Proportions of each popula- 
tion are indicated in the figure. 
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Figure 2.  Surface marker  of 
CD8-  HSA- thymocytes.  CD8- 
HSA- thymocytes  from 8-wk-old 
B10 mice were stained with anti- 
CD3  (A-D)  or  anti-TCR-c~/B 
(E-H) mAb and anti-NKl.1 (B and 
F), MEb14 (C and G), or anti-CD4 
(D and/-/) mAbs. 
c~/3 l~  or TCR-c~/3  h~h ceils were sorted by FACStar  |  (Becton 
Dickinson  & Co.).  The purity of the cells was always >99%. 
Cytotoxic Assay.  Target thymocytes were prepared from syn- 
geneic  1-4-wk-old  mice  unless otherwise  indicated.  CD4§  + 
target thymocytes were prepared by sorting. HSA- NKI.1- target 
thymocytes were prepared by treatment with anti-HSA  +  anti- 
NKI.1 mAb plus C followed by Dynabead treatment. Cytotoxic 
assay was carried out as previously reported (3, 22). Briefly, target 
cells were labeled with PKH-2 green fluorescence  dye (Zynaxis Cell 
Science, Inc., Malvern, PA) and were mixed with various numbers 
of effector ceils for 16 or 10 h in a V-bottomed 96-well microplate 
(Flow Laboratories, Inc., McLean, VA) in 200 #1 of RPMI 1640 
supplemented with 10% FCS, penicillin (100 U/ml), streptomycin 
(100 #g/ml), and 5  x  10 -s M 2-ME after centrifuge. Thereafter, 
the proportion of dead cells among PKH-2-stained cells were ana- 
lyzed by staining  the cultured  cells with propidium  iodide red 
fluorescence dye (Sigma Chemical  Co.,  St.  Louis, MO)  using 
FACScan  |  In our preliminary experiments with tumor cell targets, 
no difference was observed between this PKH-2 staining method 
and the S'Cr release assay. Data are presented as mean  _+  SD from 
triplicate cultures. 
Induction ofAnti-H.2 d CTL.  Anti-H-2  d cytotoxic T cells were 
generated by stimulating purified B10.BK lymph node T cdls with 
20-Gy irradiated B10.D2 splenocytes  for 4 d (23). Cytotoxicity  was 
determined by a 5-h assay as described above. 
Fas Antigen Transfectants.  The cDNA encoding the truncated 
mouse Fas antigen (90 amino acids had been removed from the 
COOH-terminal end) was obtained by reverse transcription PCK 
using an oligonucleotide corresponding to nucleotides 27-46 and 
740-760 of the published sequence  (24). L5178Y  cells were cotrans- 
fected  with EcoRI-digested  pMAMneo (Clontech Laboratories,  Inc., 
Palo Alto, CA), and PvuI-digested pME18S (25) containing mouse 
cDNA encoding the whole Fas molecule  (24) or the truncated mouse 
Fas molecule by electroporation at 290 V with a capacitance of 
960/xF using Gene Pulser (Bio-Rad Laboratories, Richmond, CA). 
A-1 transfectant expressing intact mouse Fas antigen or F-10 trans- 
fectant expressing truncated Fas antigen was obtained after selec- 
tion by culturing with 400 #g/ml G418 and cloning by limiting 
dilution. 
Anti-Fas mAbs.  B cell hybridomas secreting anti-Fas mAb were 
produced by fusing NS-1 mouse myeloma cells with splenocytes 
from rat immunizing with recombinant fusion soluble mouse Fas 
molecule (Nishimura, Y. and S. Yonehara, manuscript submitted 
for publication). Thereafter, a hybridoma cell line secreting anti- 
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Fas antibody (RMF6, rat IgG2a), that bound to A-1 cells but not 
to parental L5178Y cells, was cloned. 
Results 
Su~ace  Marker Analrsis  of NKI.1 + TCR-oe/~ + Thymo- 
cytes.  NKI.1 + TCR-ot/~  l~  thyrnocytes have been reported 
to  be present  in  HSA-  CD4-8-  (1,  2,  4,  9)  or  HSA- 
CD4 +  8- population (12,  13). However, direct comparison 
of CD4 and CD8 expressions on the NKI.1 + cells has not 
been  performed.  To  clarify  the  surface  characteristics  of 
NKI.1 + T cells, we first analyzed expressions of NKI.1 an- 
tigen on HSA- thymocytes. As shown in Fig.  1 A, ~12% 
of HSA-  thymocytes  expressed  NKI.1  antigens.  When 
CD4  and  CD8  expressions on  HSA-  NKI.1-  or HSA- 
NKI.1 + cells were analyzed by three-color flow cytometry, 
only CD4 +  8- and CD4-8 § populations were seen among 
the  HSA-  NKI.1-  cells  (Fig.  1 B).  By contrast,  HSA- 
NKI.1 +  cells  were  revealed  to  consist  of CD4+8 -  and 
CD4-8-  populations.  Actually no NKI.1 + ceils were de- 
tected in CD4 +  8 + and CD4- 8 + thymocyte populations. 
We then analyzed expressions of NKI.1, MEL-14, or CD4 
antigens on CD8-  HSA- thymocytes in combination with 
CD3 or TCP,-ot/3  expression. The CD8-  HSA-  thymo- 
cytes  consisted  of  CD3/TCR-ot/3 l~  and  CD3/TCR- 
Ot//3hi8  h populations (Fig. 2, A  and E). More than 99% and 
more than 98% of the NKI.1 § CD8- HSA- cells expressed 
low levels of CD3 and TCR-ot/3, respectively (Fig. 2, B and 
F). On the other hand, NKI.1 § cells expressing distinguish- 
ably low amounts of CD3/TCP,-ot/3  were MEL-14- (Fig. 
2,  C  and G). Approximately half of the NKI.1 + cells ex- 
pressed CD4 antigens (Fig. 2, D and H). In contrast, almost 
all  NKI.1-  cells expressing high amounts of CD3/TCR- 
or~3 were MEL-14 + and CD4 +. These analyses on surface 
characteristics of the HSA-  thymocytes revealed a distinct 
and  unique  NKI.1 §  CD3/TCR-ot/3 low, MEL-14-  sub- 
population in both CD4+8-  and CD4-8-  populations. 
Cytotoxicity of Freshly Isolated NKI.I + TCR-cr/~ ~  T~mo- 
cytes against Thyrnocyte Targets.  In our previous study (3), 
we found that NKI.1 + CD4-8-  TCR-ot/3  l~  thymocytes 
exhibited considerable LAK activity against thymocytes in a 4-h cytotoxic assay. However, we could not detect cytotox- 
icity  in  freshly  isolated  NKI.1 +  CD4-8-  TCR-ot/3 l~ 
thymocytes in the 4-h cytotoxic assay. Since we observed in 
this  study  (3)  that  the  NKI.1 §  CD4-8-  TCR-od3 l~ 
thymocytes showed significant redirected cytotoxicity against 
tumor cells bearing Fc receptors before these cells acquired 
LAK activity, we attempted to detect cytotoxic activity of 
freshly isolated  thymocyte subpopulations  using  different 
experimental  conditions.  When  cytotoxicity  of  purified 
CD4-8-  HSA-  MEL-14-  (double  negative,  DN)  and 
CD4+8 -  HSA-  MEL-14-  (CD4)  thymocytes,  most  of 
which were NKI.1 § cells, was evaluated against thymocyte 
targets in a 16-h cytotoxic assay, both of these two popula- 
tions exhibited considerable cytotoxicity toward syngeneic 
thymocytes (Fig. 3 A). The cytotoxicity, however, was low 
when evaluated in a 10-h cytotoxic assay (Fig. 3 B). On the 
other hand, neither unfractionated (whole) thymocytes nor 
lymph node T cells (LN T) showed any killing activity to- 
ward thymocytes (Fig. 3 A). In addition, lymph node T cell 
blasts  induced by stimulation with immobilized anti-TCR 
mAbs showed no cytotoxicity against thymocyte targets (data 
not shown). 
We then sorted CDS-  HSA-  thymocytes into NKI.1 § 
lymph node T  cells  (LN/T)  and  NKI.1-  or into  TCR- 
od3 I~  and TCR.-oe/~ high populations to confirm the popu- 
lation that is responsible for the cytotoxicity. Fig. 3 C shows 
that  NKI.1 §  or  TCR-od~ l~  population  but  neither 
NKI.1-  nor  TCR,-ot/~ high population possesses significant 
cytotoxic activity. From these observations, we conduded that 
only  NKI.1 +  TCR-od3 l~  cells  among  CD8-  HSA- 
thymocytes exhibit substantial cytotoxicity against syngeneic 
thymocytes. 
Thymocyte  Subpopulation  Susceptible  to the  Cytotoxicity  by 
NKI.1 + TCR-cr/I~ l~  Thymocytes.  Next, to determine the 
population that is susceptible to the cytotoxicity by NKI.1 + 
TCR-oe/3 l~  thymocytes, we  prepared  CD4 +  8 +  (double 
positive, DP) cells as a representative of immature thymocyte 
targets, HSA-  NKI.1-  (HSA-) cells as a representative of 
mature thymocyte targets and LN T  as a representative of 
mature peripheral T  cell targets.  NKI.1 + CD4-8-  TCR- 
or/3  l~  thymocytes killed CD4+8 + thymocytes (Fig.  4 A). 
By contrast, these NKI.1 + TCR-od3 l~  cells killed neither 
mature HSA-  NKI.1-  thymocytes nor LN T. Similarly, the 
NKI.1 +  TCR.-o//•  l~  thymocytes showed no cytotoxicity 
against NKI.1-  CD4-8-  thymocytes, although almost half 
of the CD4-8-  population was dead spontaneously in the 
16-h culture either in the absence or presence of effector cells 
(data not shown). These observations may permit us to con- 
clude that cells killed by the NKI.1 § TCR-oe//3  t~  thymo- 
cytes are CD4 +8 + thymocytes. 
When the susceptibility of target thymocytes to NKI.1 + 
effector cells was compared between young mice (1 wk old) 
and adult mice (12 wk old), thymocytes from young mice 
constantly  showed  higher  susceptibility  to  the  NKI.1 + 
thymocytes than those from adult mice did (Fig.  4 B). On 
the other hand,  no significant difference was  observed in 
proportion  of CD4+8 +  thymocytes between  young  and 
adult  mice (data  not  shown).  This  finding suggests  that 
proportion of the CD4 +  8 + subpopulation susceptible to the 
cytotoxicity by NKI.1 § killer cells is high in the thymus of 
young mice as compared with adult mice. Therefore, we used 
thymocytes from young mice as targets throughout the present 
study unless otherwise indicated. 
Requirement of Fas Expression on the Targets for Susceptibility 
to the Cytotoxicity by NKI.1 + TCR-ce/fl t~  Thymocytes.  We 
then analyzed influence of genetic differences on the suscep- 
tibility of thymocyte targets to NKI.1 + TCR-ot/3 l~  thy- 
mocytes.  CD8-  HSA-NKI.1 +  thymocytes,  in  which 
>98% of the cells were TCR-c~/3 l~  from B10.BR (H-2  k) 
mice killed both H-2 compatible (B10.BR) and H-2 incom- 
patible  (B10)  (H-2  b) thymocytes (Fig.  5 A).  Thus,  it  ap- 
peared that  H-2 differences between killer and target cells 
did not influence the cytotoxicity. However, it should be noted 
in Fig.  5 B  that when NKI.1 + thymocytes from B10.BR 
mice were analyzed for cytotoxicity toward B6 Ipr/Ipr  (H- 
2  b) or B6  +/+  thymocytes, the NKI.1 § cells exhibited only 
negligible cytotoxicity against thymocyte targets from 3-wk- 
old B6 Ipr/Ipr mice. By contrast,  the NKI.1 + thymocytes 
showed substantial cytotoxicity against B6 +/+  thymocytes. 
Similarly, the NKI.1 + thymocytes from B10.BR mice killed 
thymocytes from MR.L  +/+  (H-2  k) mice but  not  those 
from MRL Ipr/lpr mice. On the other hand, NKI.1 + TCR- 
~/3 + thymocytes from B6 Ipr/Ipr  mice showed substantial 
cytotoxicity against thymocytes from  +/+  mice (data not 
shown). 
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Figure 3.  Cytotoxicity  of 
NKI.1 + TCR-ot/3 low thymocytes 
against syngeneic thymocytes.  (.4) 
Cytotoxicity  of CD4-8-  HSA- 
MEL-14-  (DN),  CD4+8 -  HSA- 
MEL-14-  (CD4),  unfractionated 
thymocytes (whole) or LN T  (LN) 
from  B10.BR  mice  against  syn- 
geneic thymocytes. (B) Cytotoxicity 
of  CD4-8-  HSA-  MEL-14- 
(DN)  or  CD4+8 -  HSA-  MEb 
14-  (CD4) thymocytes against target thymocytes determined by a 16- (circle) or 10-h (square) cytotoxic assay. (C) Cytotoxicity of CD8-  HSA-  NKI.1- 
(open histogram, left column),  CD8 -  HSA-  NKI.1 + (solid histogram, left column),  CD8 -  HSA -  TCR-ot/3 l~  (solid histogram, right column) or CD8- 
HSA-  TCR-c~/Bhis  h (open histogram, right column) thymocytes against syngeneic thymocytes.  (E/T ratio  =  30:1). These data are representative from 
at least three independent experiments. 
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I  Figure  4.  Susceptibility  of CD4+8 +  (DP)  thymocytes  to  NKI.1 + 
TCR-odB  low thymocytes. (A) Cytotoxicity of CD4-8- HSA- MEL-14- 
thymocytes  against CD4+8 § thymocytes  (DP),  HSA- NKI.1-  thymo- 
cytes (HSA - ) or lymph node T cells (LN T). (B) Cytotoxicity of CD8 - 
HSA- MEL-14-  NK1A + thymocytes  against  thymocyte  from young (1 
wk) or adult (12 wk) mice. These data are representative of at least three 
independent  experiments. 
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Figure  6.  CD4 and CD8 expressions on thymocytes  from 3-wk-old 
B6  +/+  or B6 Ipr/Ipr mice. 
ionophor (26, 27) was compared between B6  +/+  and B6 
lpr/Ipr mice, both B6 +/+  and B6 Ipr/lpr thymocytes showed 
the same levels of susceptibility to the calcium ionophor (Fig. 
5 C). Furthermore, no difference in the proportion of major 
thymocyte subpopulations was noted between young normal 
(+/+) and young Ipr mice (Fig.  6).  Expression patterns of 
MHC class I and LFA-1 molecules on thymocytes were es- 
sentially identical between these mice (data not shown). 
Recently, the Ipr gene has been identified as a mutation 
in j~s gene that encodes Fas antigen that transduce signals 
to induce apoptosis (14-16).  Indeed, it has been reported that 
the Fas antigen is not expressed on the surface of thymocytes 
from Ipr mice, although most of thymocytes from normal 
counterpart mice (congenic at the lpr locus) express the Fas 
antigen at high levels (15, 28, 29). Thus, the present findings 
that NKI.1 + TCR-ot/~ l~  thymocytes exhibited substantial 
cytotoxicity only toward thymocyte targets of normal mice 
but not those of Ipr mice suggest that the cytotoxicity is as- 
sociated with the Fas expression on the targets. 
Cytotoxicity of NKI.1 + TCR-cr/fl ~  Thymocytes toward Tar- 
get Cells Transfected  with fas Genes.  Next, to examine directly 
the involvement of Fas antigens on the cytotoxicity, we ana- 
lyzed  cytotoxicity  of  NKI.1 +  TCR-ot//3 l~  thymocytes 
against target cells transfected with j~s gene. L5178Y (a T 
lymphoma line derived from DBA/2) cells were transfected 
with either wholeJas cDNA or mutatedj~s cDNA in which 
cytoplasmic domain is truncated (90 amino acids had been 
removed from the COOH-terminal end). Fig.  7 shows that 
the parental L5178Y cells do not express Fas antigen. By con- 
trast, J~s gene transfectants (A-l) or mutant Jhs gene trans- 
fectants (F-10)  express  significant amounts of Fas antigens 
on  their  surface.  When  these cells  were used  as  targets, 
NKI.1 + thymocytes from B10.BR mice killed A-1 transfec- 
tants more extensively than parental L5178Y  cells or F-10 
transfectants (Fig.  8 A). On the other hand, these transfec- 
tants and parental cells showed the same level of suscepti- 
bility to the cytotoxicity by anti-H-2  a CTL (Fig. 8 B). Thus, 
the  difference in  susceptibility  to  NKI.1 +  TCR-od3 l~ 
thymocytes seen among three target cell lines appears  not 
to be attributable to their different sensitivities to the cyto- 
toxic agents. It seems that intact Fas expression on the tar- 
gets is directly associated with the susceptibility to NKI.1 + 
TCR-c~/3 l~  thymocytes. 
Cytotoxic Activity of Ng1.1 + TCR-cr/~ t~  Thymocytes from 
gld Mice.  gld mice are known to have lymphoid disorders 
similar to Ipr mice (30-32). Accumulations of B220 + T cells 
are seen in lymphoid tissues that are accompanied by a large 
amount of autoantibody production in the gld mice. How- 
ever, unlike Ipr mice, Fas antigen is expressed and functions 
normally in gld mice (reference 16 and Yonehara, S., unpub- 
lished observation). It has been suggested that a mutation 
in Fas ligand molecule may occur and be the basis  of dis- 
orders observed in the gld mice (33, 34) and recently Taka- 
hashi ct al. (35) identified the point mutation in the COOH- 
terminal region of Fas ligand. 
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Figure  5.  Cytotoxicity of NKI.1 § 
TCR-a/fl I~  thymocytes against target 
thymocytes  from  different  mouse 
strains.  (A)  Cytotoxicity  of  CD8- 
HSA- MEL-14-  NKI.I+  thymocytes 
(B10.BK,  H-2  k)  against  syngeneic 
(B10.BR,  H-2  k,  open circle)  or  al- 
logeneic (B10, H-2  b, solid circle) thymo- 
cytes.  (B)  Cytotoxicity  of  CD8- 
HSA- MED14-  NKI.I+ thymocytes 
(B10.BR) against thymocytes from 3-wk-old B6  +/+  (open circle) or B6 lpr/lpr mice of the same age (solid circle). (C) Viability of thymocytes cultured 
in the presence of calcium ionophor (A23187) to induce apoptosis (B6  +/+, open circle, B6 lpr/lpr, solid circle). These data are representative from three 
independent  experiments. 
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Figure  7.  Fas antigen expression on transfectants. Parental L5178Y (T cell lymphoma  derived from DBA/2 mice [H-2d]), truncated Fas antigen 
expressing cells (F-10) or normal Fas antigen  expressing cells (A-l) were stained  with anti-Fas  mAb (RMF6) plus FITC-anti-rat  IgG (open histogram) 
or only with FITC anti-rat IgG (hatched histogram). 
We then, purified NKI.1 § cells from the thymus of gld 
mice and analyzed their cytotoxicity against thymocyte targets. 
Fig. 9 A  shows that the NKI.1 + thymocytes from gld mice 
do not kill thymocyte targets from normal mice. On the 
other hand, when susceptibility of target thymocytes to the 
NKI.1 +  effector cells  from normal  (B6  +/+)  mice was 
compared between gld  mice and normal mice, thymocytes 
from gld mice showed slightly but consistently higher sus- 
ceptibility than those from normal mice (Fig.  9 B). These 
results support interpretation for our present experimental 
results that NKI.1 + TCR  l~  thymocytes kill targets at least 
in some part via Fas antigen-Fas ligand interaction. 
Discussion 
NKI.1 §  TCI~-oJ3  l~  thymocytes are  detected in both 
CD4-8-  and CD4 +  8-  thymocyte populations (4,  9,  12). 
In spite of extensive analysis of this population, physiolog- 
ical role of the NKI.1 § TCR-od3  l~  thymocytes has been 
unclear.  In the present study, using a 16-h cytotoxic assay 
we demonstrated that freshly isolated NKI.1 + TCR-od3  l~ 
thymocytes exhibited significant cytotoxicity against thymo- 
cyte targets from either syngeneic or allogeneic mice.  Fur- 
thermore, the target population susceptible to the killing ac- 
tivity by NKI.1 + TCR-a/[3  l~  thymocytes was revealed to 
be immature CD4+8 + thymocytes. Although it took a long 
time (16 h) for the NKI.1 + TCR-a/B  1~  thymocytes to ex- 
press  detectable  levels  of  cytotoxicity  against  CD4+8 § 
thymocytes in vitro as compared with conventional CTL, 
NK, or LAK cells, it seems interesting and somewhat sur- 
prising that effector (killer) cells and their target cells are coex- 
isting within the same organ: the thymus. 
Furthermore,  we  found  that  NKI.1 +  TCR-od3  l~ 
thymocytes did not exhibit significant cytotoxicity against 
CD4 +  8 + thymocytes from Ipr mice. The Ipr mice have re- 
cently been reported to carry mutatedfas gene in which early 
transposon is inserted (16, 36-38).  In fact extensively low 
levels of Fas expression  are noted on thymocytes in Ipr mice 
(15, 29). Thus, the present finding that thymocytes from Ipr 
mice but not from +/+  normal mice were resistant to cyto- 
toxicity by NKI.1 + TCR-oe/fl  l~  thymocytes suggests the 
involvement of Fas antigen in the cytotoxicity. Furthermore, 
NKI.1 +  TCR-ol/3 l~  cells  killed  the  T  lymphoma line 
transfected with jas genes but killed neither the parental T 
lymphoma line nor the T  lymphoma line transfected with 
Jas genes in which the cytoplasmic domain is truncated. On 
the other hand, these T  lymphoma lines showed the same 
levels of susceptibility to CTLs specific for H-2  a alloantigens. 
Thus, these experimental results may permit us to conclude 
that Fas antigen and subsequent signaling from Fas are directly 
involved in the killing by NKI.1 + TCR-oe/3  l~  thymocytes. 
This postulate is supported by the finding of the last ex- 
periment that NKI.1 + thymocytes from gld mice could not 
kill CD4 +  8 +  thymocytes from normal mice.  It has been 
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Figure 8.  Cytotoxicity of  NKI.1  +  TCR-ce//8  l~ 
thymocytes  against Fas antigen transfectants. (A) Cyto- 
toxicity  of CD8- HSA- MEb14- NKI.1  + thymoc/tes 
from B10.BE  mice  against  L5178Y (solid circle), F-10 (open 
circle) or A-1 (solid triangle) cells. Cytotoxicity  was deter- 
mined  by a 16-h assay.  (/3) Cytotoxicity  of anti-H-2  d c/to- 
toxic T cells  against  L5178Y (solid circle), F-10 (open circle) 
or A-1 (solid triangle) cells. These data are representative 
from three independent experiments. 
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Figure  9.  Cytotoxicity and susceptibility of thymocytes from gld mice. 
(A) Cytotoxicity of NKI.1 + TCR-c~/3  l~  thymocytes from B6  +/+  mice 
(open circle) or B6 gld/gld mice (solid circle) against thymocyte targets from 
86  +/+  mice were analyzed. (B) Cytotoxicity of NKI.1 + TCR-c~/3  l~ 
thymocytes from B6  +/+  mice against thymocyte targets from 6-wk-old 
B6  +/+  (open circle) or B6 gld/gld mice (solid circle) were analyzed. These 
data  are representative  from three  independent  experiments. 
suggested that Ipr and gld autoimmune prone mice carry mu- 
tations  of genes encoding  an interacting  pair of molecules 
involved in T cell development (33) and very recently a point 
mutation in the Fas ligand was determined  in the gld mice 
(35). In gld mice, Fas antigen is normally expressed (16) and 
can ddiver signals for apoptosis into thymocytes (Yonehara, 
S.,  unpublished  observation).  Thus,  it  seems that  NKI.1 + 
thymocytes ofgld mice carrying defective Fas ligand can not 
kill the normal CD4 +  8 + thymocytes. This interpretation  is 
consistent with  the next  finding  that  CD4 +  8 + target  thy- 
mocytes from gld mice showed consistently higher sensitivity 
than  those  from  +/+  mice  of the  same  age  to  NKI.1 + 
TCR-cff~/l~  killer  population of normal mice.  We reasoned 
that  the CD4 § 8 + thymocytes from gld mice which might 
not have been killed in vivo exhibited high sensitivity to the 
NKI.1 + killer  cells  of normal  mice.  These  results  suggest 
strongly the contribution  of the Fas antigen-Fas  ligand in- 
teraction  on  the  cytotoxicity  by  NKI.1 +  TCR-oJB  l~ 
thymocytes and may interpret,  at least in part, the immuno- 
logical disorders  seen  in  Ipr and gld mice. 
A similar killing system via Fas molecule was reported by 
Rouvier et al. (39). These authors reported that certain kinds 
of CTLs which had been stimulated with target antigens in 
vivo showed both Fas- and non-Fas-mediated cytolysis. Rat 
Fas ligand  was cloned  from  a novel (rat  x  mouse)  T  cell 
hybridoma and demonstrated to be a molecule of TNF family 
(40). Although we attempted to detect Fas ligand expression 
on NKI.1 + TCR-oL/B  l~  thymocytes using a soluble form 
of recombinant  Fas molecules, we could not detect the ex- 
pression of the Fas ligand on the effector cells (data not shown). 
Suda et al.  (40) reported that  stimulation  of rat spleen cells 
with Con A significantly increased mRNA for the Fas ligand. 
Therefore, activation of T cells seems to elevate levels of the 
Fas ligand expression, which eventually results in induction 
of Fas-mediated CTL. Thus, the expression of Fas ligand on 
freshly isolated NKI.1 + TCR-c~/~  l~  thymocytes might  not 
reach a detectable level when we analyzed them in the present 
study.  Alternatively,  NKI.1 § TCR-c~/~ § thymocytes may 
deliver signals  to Fas molecules using unknown  molecules 
different from the integral membrane Fas ligand. These points 
should be pursued in further studies in which more efficient 
detection  system of routine  Fas ligand  is introduced. 
At present, it has remained unclear whether recognition of 
antigens by TCR is involved in the cytotoxicity by NKI.1 § 
TCR-c~/~ I~  thymocytes against CD4 +  8 + thymocytes. The 
NKI.1 + TCR-c~/3 l~  thymocytes express skewed TCR V3 
family and express self Mls-1 ~ reactive V38.1  TCR in Mls- 
1  a mice  (1,  2,  5,  12).  Recent  analysis  of 32-microglobulin 
deficient mice revealed  that the predominant  V~8.2 expres- 
sion in CD4-8-  TCR-oJ3 + thymocytes results from posi- 
tive selection by self-antigen presented on MHC class I (41). 
Similarly,  we have  found  that  the  proportion  of NKI.1 § 
CD4 +  8-  TCR-c~/3 l~  thymocytes is significantly reduced 
in  32-microglobulin-deficient  mice  (Arase,  H.,  N.  Arase, 
and K.  Ono6,  unpublished  observation).  It seems that  the 
NKI.1 + TCR-cr/3 l~  thymocytes may recognize certain an- 
tigens associated with class I antigen in the absence of CD8 
coreceptors  and  in  this  way acquire  Fas-mediated cytotox- 
icity against  CD4 +8 +  thymocytes.  However, it  should be 
taken  into  consideration  that  the cytotoxicity by NKI.1 + 
TCR-cr  l~  thymocytes was shown to cross the H-2 bar- 
rier  and  that  CD4+8 §  target  thymocytes  express  low 
amounts  of classical  class  I  antigen. 
Thymocytes  are  known  to  be  positively  or  negatively 
selected  and  most  of thymocytes  die  by apoptosis  before 
they mature  into  CD4+8 -  or  CD4-8 +  thymocytes from 
CD4+8 + thymocytes.  We demonstrated  herein  that  a sub- 
population  of CD4 +8 + thymocytes appeared  to be targets 
for  NKI.1 +  TCR-c~/3  l~  killer  cells  in  vitro.  Thus,  it 
seemed that  NKI.1 +  TCR-cr  l~  thymocytes might  con- 
tribute to the negative selection in the thymus. However, T 
cells with endogenous superantigen reactive TCR repertoire 
are almost  normally  eliminated  in  lpr mice (42-44).  Simi- 
larly,  the T  cells with  self-reactive TCR have been already 
eliminated in newborn mice in which NKI.1 § TCR-c~/3 § 
thymocytes are hardly detected. Thus, it seems to us that the 
cytotoxicity of the NKI.1 + TCR-oJ3 I~  thymocytes toward 
immature thymocytes is not directly related to the clonal elimi- 
nation  of self-reactive T  cells. 
In  Ipr and gld  mice,  abnormal  B220 +  CD4-8-  TCR- 
ot/3 ~ cells  accumulate  in lymphoid  tissues of adult  mice. 
Although  the exact origin  of the B220 + CD4-8-  T  cells 
is unclear,  several reports have suggested that these cells are 
derived from CD4 § 8 + thymocytes (42,  45-47).  Thus,  the 
defect  of cytotoxicity of NKI.1 §  TCR-c~/~ +  thymocytes 
against  CD4+8 §  thymocytes  may be correlated  with  ab- 
normal T  cell development in Ipr and gld mice. In addition, 
a high production rate of whole CD4 § 8 + thymocyte popu- 
lation  as compared with  normal  mice has been reported in 
Ipr mice  (45). 
Both  CD4-8-  NKI.1 §  TCR-cff3  I~  and  CD4+8 - 
NKI.1 + TCR-od3 l~  thymocytes appear late in  life  (1,  5, 
12). On the other hand, it was shown that culture of TCR- 
c~/3-  cells  in bone marrow  generated  in  CD4-8-  TCR- 
ot/3 § cells (48, 49).  Furthermore,  Kikly and Dennert  (50) 
reported  that  NKI.1 +  CD4-8-  TCR-od3  ~~  T  cells  in 
bone marrow could differentiate in extrathymic tissues. Thus, 
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are generated not only in the thymus (51) but also in ex- 
trathymic tissues. The latter population may enter the thymus 
after full differentiation. Indeed, it has been reported that 
activated T  cells can enter the thymus (52,  53).  Taken to- 
gether, these cells seem to have differentiated in a way different 
from major CD4 + or CD8 + T cells. Furthermore, propor- 
tions of NKI.1 + T  cells are relatively high in the thymus 
(4,  12), bone marrow (12, 54),  and liver (reference  55 and 
Arase, H., unpublished observation), although the NKI.1 + 
TCR-ot/fl  l~  cells  are  detectable  in  almost  all  lymphoid 
organs. Thus, the target cells killed by the NKI.1 + TCR- 
or//3  l~  T  cells may not be restricted to CD4+8 + thymo- 
cytes. Further analysis of the NKI.1 + TCR-c~//3 + cells dis- 
tributed to a variety of tissues will be needed to clarify the 
total functions of the cells. 
A T cell population similar to that shown in the murine 
system has been reported in human. In the thymus (56) and 
peripheral blood (57), T cells with natural killer cell marker 
such as CD56  (NKH-1)  have been detected.  In  addition, 
human  CD4-8-  TCR-ot/13 §  cells  express  unique  TCR 
repertoire like murine CD4-8-  TCR-ot/fl  l~  T  cells (58, 
59)  and a certain repertoire among these CD4-8-  TCR- 
a/B + cells  has been  shown to be  specific for class I-like 
CD1 molecules (60). On the other hand, Fas antigen is also 
expressed on most of the human thymocytes (Yonehara, S., 
Y. Kobayashi, and Y. Nishimura, manuscript submitted for 
publication). Therefore, the similar regulatory mechanism 
mediated by NK-like T cells may play a role even in human 
system. 
In conclusion, we have demonstrated herein that freshly 
isolated  NKI.1 +  TCR-cc/B  l~  thymocytes  kill  directly 
CD4 +  8 + thymocytes expressing  Fas antigens.  Although we 
have not elucidated the recognition system of the NKI.1 § 
TCR-ot/~  l~  cells,  these findings appear  to be  important 
when the physiological role of NKI.1 + TCR-ot/fl  l~  thy- 
mocytes and the Fas antigen expressed on most thymocytes 
are considered. The defective interaction between NKI.1 § 
TCR-ot//3  l~  killer thymocytes and target CD4 +  8 + thymo- 
cytes seems to be related to lymphoid disorders seen in both 
lpr and gld mice (33,  35). 
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